🦊/People

Glenn Pierce

Investor

Investment Committee Co-Chair at Pathway to Cures · Director at Voyager Therapeutics, Inc.

Boston, Massachusetts, United States

Find your path to Glenn

624 people in our graph share verified history with Glenn — schools, employers, funds. One of them is your warm intro.

Lisa PurcellunlockedGlenn: together at Third Rock Ventures (2024–2025)
×7Glenn: together at Third Rock Ventures
×3Glenn: together at Case Western Reserve University
Glenn: together at Bayer HealthCare

About

Pierce is an independent consultant and entrepreneur-in-residence at Third Rock Ventures with 30 years of biotech R&D experience. He retired from Biogen in 2014 as SVP of Hematology, Cell and Gene Therapies.

Director at Voyager Therapeutics, Inc.

Intro paths

In turn, Glenn can intro founders to Voyager Therapeutics, Inc.'s investors below.

Experience

  1. Typewriter, Frontera, Be Bio (to 2026), Metagenomi (to 2026), hC Bio (to 2025), Decibel (to 2023)Scientific Advisory Boardcurrent2020 — presentBoston, San Francisco
  2. Global Blood Therap (2016-22), Voyager Therapeutics (2017-), World Federation of Hemophilia 2015-26Directorcurrent2016 — present
  3. Self EmployedVolunteer, Consultant, Advisorcurrent2015 — present
  4. World Federation of Hemophilia / Fédération mondiale de l'hémophilieVice President, Medical2018 — 2026Greater Montreal Metropolitan Area
  5. Third Rock VenturesEntrepreneur In Residence2016 — 2025San Francisco Bay Area
  6. Voyager Therapeutics, Inc.Interim CSO2021 — 2022Cambridge, Massachusetts, United States
  7. Ambys MedicinesInterim CMO2018 — 2022San Francisco Bay Area
  8. Hiatus-2014 — 2016
  9. BiogenSVP, Hematology, Cell and Gene Therapies2014
  10. BiogenSVP, Global Medical Affairs and Chief Medical Officer, Hemophilia Therapeutic Area2012 — 2014
  11. BiogenSVP and CMO Hemophilia Business2009 — 2012
  12. Bayer HealthCareScientific Head, US Research Center/VP Applied Research2005 — 2009
  13. AvigenVice President Research/Development2002 — 2005
  14. Selective GeneticsVice President, Therapeutic Product Development1994 — 2002
  15. AmgenAssoc Med Director1988 — 1994

Skills & more

Clinical Development99Immunology66Pharmacology38Hematology43Polymers2Partnerships4Biotechnology68Lifesciences7Pharmaceutical Industry39Technology Transfer17Oncology13Drug Discovery22
+8 moreClinical TrialsLipidTissueBiopharmaceuticalsDrug DevelopmentFDACommercializationMolecular Biology

From Glenn's professional profile.

Colleagues at Pathway to Cures

Frequently asked questions

Who is Glenn Pierce?
Pierce is an independent consultant and entrepreneur-in-residence at Third Rock Ventures with 30 years of biotech R&D experience. He retired from Biogen in 2014 as SVP of Hematology, Cell and Gene Therapies.
Where does Glenn Pierce work?
Glenn Pierce is Investment Committee Co-Chair at Pathway to Cures.
Where did Glenn Pierce go to school?
Glenn Pierce studied at Washington University School of Medicine in St. Louis (Lab Medicine Residency and Hematology Fellowship/Post-doc); Case Western Reserve University School of Medicine (Internship, Internal Medicine); Case Western Reserve University School of Medicine (MD, PhD).

Same school

Shared employers